Moneycontrol
HomeNewsBusinessMoneycontrol ResearchZydus Lifesciences: Why we are getting constructive
Trending Topics
Sensex Live
Excelsoft Technologies Share Price
Sudeep Pharma IPO Allotment Status
New Labour Code
Gold Price

Zydus Lifesciences: Why we are getting constructive

Anubhav Sahu   •

There is a steady progress in product approvals and clinical trials for Zydus' niche products meant for rare ailments

On the biosimilar front, while Zydus is focused on consolidating its domestic business of 13 products, it is also investing in trials for new products

To read the full story,

Subscribe to Moneycontrol PRO
  • Ad-free Experience
  • Access Exclusive Stories
  • Weekly Investment Ideas
  • Daily Technical Calls

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More